Medical technology investor SHS raises over €90 million

Please login or
register
20.07.2018
medical technology

SHS Gesellschaft für Beteiligungsmanagement has received capital commitments of over €90 million in its fifth fund's first closing. The fifth generation of SHS funds is also focused on the life sciences and medical technology sector, and thus on the growing global healthcare market with innovative and strong players, especially in Germany and Switzerland.

The Tuebingen-based medical technology investor has thus almost two thirds of its target of €150 million faster than expected. Investment in between 12 and 15 companies is planned. The investment firm regards minimally invasive surgical procedures, robot-assisted forms of treatment or digital solutions for the health sector as particularly innovative high-growth fields. The industry expertise, the availability of well-trained engineers, and above all the close integration between the academic and business environments have created a favorable climate in the industry in Germany and Switzerland.

According to SHS, the fifth fund will invest up to €30 million per transaction. Together with partners, equity transactions of up to €60 million can be realized. Both majority and minority shareholdings are possible. The focus is on expansion and innovation financing, succession situations and changes in shareholder structures. SHS is expanding its current focus on Germany, Austria and Switzerland to include Scandinavia and the Benelux countries.

Around half of the investors in SHS V had already invested in the company's previous funds. SHS attributes the strong demand from institutional investors and family offices to its positioning as a sector specialist. "We would like to thank the investors for their trust in us. For 25 years now, we have concentrated on investments in companies in the medical technology and diagnostics sectors. We have developed extensive industry experience and trust, and also have a good sense for feasible innovations. Our portfolio companies can rely on an established network of industry experts, health insurance companies and medical opinion leaders. In addition to this, we help the companies improve performance with our internationalization know-how and expertise with regard to reimbursement and regulations as well as in the initiation of strategic partnerships," says Hubertus Leonhardt, SHS partner and Managing Director responsible for fundraising.

More news about SHS can be found in Startupticker’s investor database.

(Press release)

0Comments

rss